AstraZeneca Forecasts Continued Growth on Pipeline Strength

Core Insights - The company anticipates revenue growth for 2026 to be in the mid-to-high single-digit percentage range, indicating a positive outlook for future sales performance [1] - Core earnings per share are expected to increase by a low double-digit percentage, reflecting strong profitability expectations [1]